CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- 4 Open-market sale Chief Medical Officer sold 11,983 shares at an average $19.31 ($231,396)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Other events
- 4 Open-market sale President and CEO sold 91,052 shares at $20.23 ($1,841,982)
- 8-K Event Material agreement · Unregistered share sale · Other events
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award SVP, Finance & Accounting acquired 21,250 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 15,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Legal Officer acquired 46,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 4 Gift President and CEO gave 3,000 shares (gift)
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
Page 13 of 41 · 809 filings